SABCS 2024: Imlunestrant Monotherapy and Combination with Abemaciclib Show Promising Efficacy and Safety in Metastatic ...
In an interview with Pharmacy Times®, Komal Jhaveri MD, FACP, Breast Medical Oncologist and Early Drug Development Specialist at Memorial Sloan Kettering Cancer Center, discussed results from the EMBER-3 trial, which evaluated the efficacy and safety of …